Sartorius stock reports 7.7 percent H1 sales growth

Published on 10/04/2026 at 16:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius stock was last at EUR 251.40 on October 2, 2026, while H1 sales grew 7.7 percent operationally. The margin reached 30.3 percent.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern — Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius stock (ISIN DE0007165631) was last at EUR 251.40 on Xetra on October 2, 2026, up 0.16 percent from the prior session. The company reported 7.7 percent operational sales growth for the first half of 2026 and an underlying EBITDA margin of 30.3 percent, keeping the focus on execution before the next quarterly report.

H1 growth supports guidance

Sartorius lists its half-year 2026 results and guidance on the investor-relations page. Management expects fiscal 2026 sales growth of between 5 and 9 percent in constant currencies and an underlying EBITDA margin above 30 percent, compared with 29.7 percent in fiscal year 2025.

The H1 margin of 30.3 percent is already above the prior-year benchmark cited in the guidance, while operational sales growth gives the upcoming report a measurable starting point. Bioprocess Solutions remains the larger growth engine, whereas Lab Products and Services is tied to a recovery in instruments and continued demand for consumables and services.

Analyst targets move higher

On September 30, 2026, FinanzNachrichten reported that Barclays raised its Sartorius price target from EUR 300 to EUR 310 while retaining an Overweight rating. Analyst Charles Pitman-King expected the company to reach the middle of its annual guidance corridor.

A separate MarketScreener overview dated September 11, 2026, showed an Outperform consensus from 20 analysts and an average price target of EUR 271.74. That target is higher than the October 2 Xetra price, but the October report remains the next concrete test of the recovery narrative.

Q3 report arrives October 21

MarketScreener lists October 21, 2026, as the Q3 2026 earnings release date. The report will show whether the 7.7 percent H1 sales trajectory and 30.3 percent margin can support management's 2026 targets after tariff and demand pressures shaped the first half.

Sartorius stock holds near EUR 251

Sartorius preference shares were last at EUR 251.40 on Xetra on October 2, 2026, with a daily gain of 0.16 percent. The price, H1 growth rate and margin give investors three concrete markers before the October earnings release.